Glucocorticoid and immunoglobulin to treat viral fulminant myocarditis
Open Access
- 27 April 2020
- journal article
- editorial
- Published by Oxford University Press (OUP) in European Heart Journal
- Vol. 41 (22), 2122
- https://doi.org/10.1093/eurheartj/ehaa357
Abstract
This Commentary refers to: ‘Coronavirus fulminant myocarditis saved with glucocorticoid and human immunoglobulin’, by H. Hu et al., doi:10.1093/eurheartj/ehaa190.Funding Information
- National Key R&D Program of China (2017YFC1307800)
This publication has 5 references indexed in Scilit:
- Coronavirus fulminant myocarditis treated with glucocorticoid and human immunoglobulinEuropean Heart Journal, 2020
- Recognition and Initial Management of Fulminant MyocarditisCirculation, 2020
- Ätiologie, Diagnose, Management und Therapie der MyokarditisHerz, 2013
- Corticosteroids for viral myocarditisEmergencias, 2013
- Therapy with immunoglobulin in patients with acute myocarditis and cardiomyopathy: analysis of leukocyte balanceHeart and Vessels, 2013